Global Blood Therapeutics Inc (NASDAQ:GBT)
| 61.93 Delayed Data As of Aug 13 |  +0.29 / +0.47%Today’s Change | 39.95 Today|||52-Week Range 87.54 | -22.09% Year-to-Date |
Latest GBT News | Press Releases
No recent news for Global Blood Therapeutics Inc.
Today’s Trading
| Previous close | 61.63 |
| Today’s open | 61.54 |
| Day’s range | 60.63 - 62.33 |
| Volume | 723,049 |
| Average volume (3 months) | 886,574 |
| Market cap | $4.0B |
Data as of 3:59pm ET, 08/13/2020
Growth & Valuation
| Earnings growth (last year) | -34.31% |
| Earnings growth (this year) | +21.17% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 2,199.23 |
| Price/Book | 6.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FOLDAmicus Therapeutics ... | +0.06 | +0.41% |
| ARNAArena Pharmaceutical... | +1.86 | +2.93% |
| BHVNBiohaven Pharmaceuti... | +2.76 | +4.65% |
| ---- |
Data as of 4:00pm ET, 08/13/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.79 |
| Annual revenue (last year) | $2.1M |
| Annual profit (last year) | -$266.8M |
| Net profit margin | -12,654.93% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
